Charlotte Beau-Larvor
11Patents
2h-index
10Co-inventors
43Inventor score
Filing activity: Nov 5, 2012 → Feb 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9173962B2 | Antigen binding protein and its use as addressing product for the treatment of cancer | Physics | 9 | Active |
| US10202458B2 | IGF-1R antibody and its use as addressing vehicle for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US10633448B2 | IGF-1R antibody-drug-conjugate and its use for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10858423B2 | Composition for the treatment of IGF-1R expressing cancer | Human Necessities | 1 | Active |
| US9624308B2 | Antigen binding proteins | Chemistry; Metallurgy | 1 | Active |
| US10314921B2 | Antibody-drug-conjugate and its use for the treatment of cancer | Human Necessities | 1 | Active |
| US11365259B2 | IGF-1R antibody and its use as addressing vehicle for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10161930B2 | Antigen binding protein and its use as addressing product for the treatment of cancer | Physics | 1 | Active |
| US9689862B2 | Antigen binding protein and its use as addressing product for the treatment of cancer | Physics | 1 | Active |
| US11219693B2 | Antibody-drug-conjugate and its use for the treatment of cancer | Human Necessities | 0 | Active |
| US11661457B2 | IGF-1R antibody-drug-conjugate and its use for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.